Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 02, 2022 07:30 ET | Source: Merakris Therapeutics

Study Shows Effectiveness of Merakris’ Wound Care Products

RESEARCH TRIANGLE PARK, N.C., June 02, 2022 (GLOBE NEWSWIRE) -- A peer-reviewed case study in the May 21 edition of SAGE Open Medical Case Reports highlights the effectiveness of two Merakris...
July 20, 2021 06:30 ET | Source: Merakris Therapeutics

Merakris Announces Agreement With Miracles In Sight Eye Bank To Supply Opticyte® Repair Grafts to Eye Surgeons

RESEARCH TRIANGLE PARK, N.C., July 20, 2021 (GLOBE NEWSWIRE) -- Research Triangle Park-based biotechnology company Merakris Therapeutics has reached an agreement with Miracles In Sight (MIS) to...
October 01, 2018 10:45 ET | Source: BioStem Technologies, Inc.

BioStem Life Sciences, Inc., Subsidiary of BioStem Technologies, Inc., Announces Entry into Market with Four Amniotic Products

Pompano Beach, FL, Oct. 01, 2018 (GLOBE NEWSWIRE) -- BioStem Life Sciences (“Life Sciences” or the “Company”), a wholly owned subsidiary of BioStem Technologies, Inc. (OTC PINK: BSEM), a...
October 06, 2015 05:00 ET | Source: AmnioLife Corporation

AmnioLife to Participate at First Annual Interventional Orthopedic Foundation Conference October 23rd & 24th

GAINESVILLE, Fla., Oct. 06, 2015 (GLOBE NEWSWIRE) -- AmnioLife Corporation, a human cells, tissues, and cellular and tissue-based products developer, today announced that its CEO and Lead Scientist...
June 03, 2015 06:30 ET | Source: AmnioLife Corporation

FL-Based Biotech, AmnioLife Corp. Closes $833K in Series A

GAINESVILLE, Fla., June 03, 2015 (GLOBE NEWSWIRE) -- AmnioLife Corporation, a human cells, tissues, and cellular and tissue-based products developer, today announced it has raised $833K in a Series...